GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » Market Cap

Atrys Health (XMAD:ATRY) Market Cap : €293.1 Mil (As of Jun. 06, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Atrys Health Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Atrys Health's share price for the quarter that ended in Dec. 2023 was €3.67. Atrys Health's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 75.9 Mil. Therefore, Atrys Health's market cap for the quarter that ended in Dec. 2023 was €278.7 Mil.

Atrys Health's quarterly market cap declined from Dec. 2022 (€470.5 Mil) to Jun. 2023 (€394.4 Mil) and declined from Jun. 2023 (€394.4 Mil) to Dec. 2023 (€278.7 Mil).

Atrys Health's annual market cap declined from Dec. 2021 (€622.7 Mil) to Dec. 2022 (€470.5 Mil) and declined from Dec. 2022 (€470.5 Mil) to Dec. 2023 (€278.7 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Atrys Health's Enterprise Value for Today is €512.2 Mil.


Atrys Health Market Cap Historical Data

The historical data trend for Atrys Health's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Market Cap Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial 127.94 308.28 622.71 470.54 278.68

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 622.71 483.06 470.54 394.42 278.68

Competitive Comparison of Atrys Health's Market Cap

For the Biotechnology subindustry, Atrys Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Market Cap distribution charts can be found below:

* The bar in red indicates where Atrys Health's Market Cap falls into.



Atrys Health Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Atrys Health's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€3.67*75.9343
=€278.7

Atrys Health's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€3.67*75.9343
=€278.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Atrys Health  (XMAD:ATRY) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Atrys Health Market Cap Related Terms

Thank you for viewing the detailed overview of Atrys Health's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health (XMAD:ATRY) Business Description

Traded in Other Exchanges
Address
c/ Provença, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health (XMAD:ATRY) Headlines

No Headlines